Publications by authors named "M Tuncbilek"

Claim this Profile
T
Targeting Ovarian Cancer With Pyrimidine Nucleobase and Nucleoside Analogs: Synthesis, In Vitro Cytotoxic Activity, and Molecular Docking.
Hilal Zivali, Arya Akdağ, Büşra Demirkan, İrem Durmaz Şahin, Meral Tunçbilek

Arch Pharm (Weinheim)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and cytotoxicity of novel 6,8,9-trisubstituted purine analogs against liver cancer cells.
M Fatih Polat, Irem Durmaz Şahin, Pınar Kul, Rengul Cetin Atalay, Meral Tuncbilek

Bioorg Med Chem Lett· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Newly synthesized 6-substituted piperazine/phenyl-9-cyclopentyl containing purine nucleobase analogs act as potent anticancer agents and induce apoptosis inhibiting Src in hepatocellular carcinoma cells.
Ebru Bilget Guven, Irem Durmaz Sahin, Duygu Altiparmak, Burak Servili, Sebnem Essiz, Meral Tuncbilek

RSC Med Chem· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploration of novel 6,8,9-trisubstituted purine analogues: synthesis, in vitro biological evaluation, and their effect on human cancer cells.
Muhammed Fatih Polat, İrem Durmaz Şahin, Rengül Atalay, Meral Tunçbilek

Turk J Chem· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel 6,8,9-Trisubstituted Purine Analogue Drives Breast Cancer Luminal A Subtype MCF-7 to Apoptosis and Senescence through Hsp70 Inhibition.
Pinar Kul, Meral Tuncbilek, Mustafa Ergul, Ezgi Nurdan Yenilmez Tunoglu, Yusuf Tutar

Anticancer Agents Med Chem· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis